Travere Therapeutics, Inc. (TVTX)
52.12
+0.08
(+0.16%)
USD |
NASDAQ |
Oct 09, 16:00
52.17
+0.04
(+0.09%)
After-Hours: 20:00
Travere Therapeutics Gross Profit Margin (Quarterly) : 96.22% for June 30, 2026
Gross Profit Margin (Quarterly) Chart
Historical Gross Profit Margin (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2026 | 96.22% |
| March 31, 2026 | 78.65% |
| December 31, 2025 | 84.05% |
| September 30, 2025 | 89.46% |
| June 30, 2025 | 86.42% |
| March 31, 2025 | 78.61% |
| December 31, 2024 | 80.42% |
| September 30, 2024 | 79.55% |
| June 30, 2024 | 77.08% |
| March 31, 2024 | 72.49% |
| December 31, 2023 | 63.57% |
| September 30, 2023 | 65.59% |
| June 30, 2023 | 73.38% |
| March 31, 2023 | 65.15% |
| December 31, 2022 | 65.34% |
| September 30, 2022 | 74.12% |
| June 30, 2022 | 81.24% |
| March 31, 2022 | 80.96% |
| December 31, 2021 | 84.35% |
| September 30, 2021 | 86.13% |
| June 30, 2021 | 84.86% |
| March 31, 2021 | 83.97% |
| December 31, 2020 | 84.25% |
| September 30, 2020 | 85.90% |
| June 30, 2020 | 86.00% |
| Date | Value |
|---|---|
| March 31, 2020 | 85.29% |
| December 31, 2019 | 84.97% |
| September 30, 2019 | 85.31% |
| June 30, 2019 | 86.98% |
| March 31, 2019 | 85.47% |
| December 31, 2018 | 85.58% |
| September 30, 2018 | 85.85% |
| June 30, 2018 | 86.28% |
| March 31, 2018 | 84.49% |
| December 31, 2017 | 86.62% |
| September 30, 2017 | 86.27% |
| June 30, 2017 | 86.81% |
| March 31, 2017 | 85.15% |
| December 31, 2016 | 85.57% |
| September 30, 2016 | 83.30% |
| June 30, 2016 | 85.03% |
| March 31, 2016 | 83.98% |
| December 31, 2015 | 84.97% |
| September 30, 2015 | 84.33% |
| June 30, 2015 | 81.54% |
| March 31, 2015 | 88.18% |
| December 31, 2014 | 92.73% |
| September 30, 2014 | 75.47% |
| June 30, 2014 | 71.06% |
| March 31, 2014 | -359.1% |
Gross Profit Margin Definition
Gross Profit Margin is calculated using Gross Profit/Revenue. This metric measures the overall efficiency of a company in being able to turn revenue into gross profit and doing this by keeping cost of goods sold low. An analyst looking at gross profit margin might look for a higher gross profit margin relative to other comparable companies as well as a gross profit margin that is growing.
Gross Profit Margin (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Gross Profit Margin (Quarterly) Benchmarks
| TG Therapeutics, Inc. | 82.86% |
| BioMarin Pharmaceutical, Inc. | 72.27% |
| Vertex Pharmaceuticals, Inc. | 85.37% |
| Viridian Therapeutics, Inc. | 58.80% |
| Krystal Biotech, Inc. | 93.46% |
Gross Profit Margin (Quarterly) Related Metrics
| Return on Equity | -98.26% |
| Return on Assets | -11.08% |
| Return on Invested Capital | -14.42% |
| Profit Margin (Quarterly) | -20.52% |
| Operating Margin (Quarterly) | 2.33% |
| Return on Net Operating Assets | -32.46% |